Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Laboratory Corporation of America Holdings Sees FY 2013 Revenue Guidance At Top End Of Prior Range; Widens FY 2013 EPS Guidance


Friday, 18 Oct 2013 06:45am EDT 

Laboratory Corporation of America Holdings announced that for Fiscal 2013, it expects revenue growth of approximately 3%; Adjusted EPS Excluding Amortization of $6.95 to $7.05. The guidance includes the negative impact of approximately $0.35 due to Medicare payment reductions. The Company reported revenue of $5.671 billion in fiscal 2012. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $5.793 billion for fiscal 2013. 

Company Quote

107.39
0.69 +0.65%
30 Oct 2014